Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Wallen

Showing results (121-130 of 144) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinomaC Lance Cowey, Chirag Amin, Raj S Pruthi, et al.
Urology Practice|March 31, 2026
Early Subspecialization Alignment: How Residents Tailor Experiences Before FellowshipSri Saran Manivasagam, Raidizon Mercedes, Gary E Lemack, et al.
Journal of Surgical Education|January 23, 2025
Impact of Subsequent Fellowship on Urology Chief Resident Case Log VolumesRaidizon Mercedes, Zachary Corey, Talmadge Gaither, et al.
Urology Practice|August 28, 2024
Practice Readiness? Trends in Chief Resident Case Logs vs Subsequent Case Log Data in Clinical PracticeZachary Corey, Erik Lehman, Gary E Lemack, et al.
The Journal of Urology|May 8, 2024
Decisional Conflict Among Patients Newly Diagnosed With Clinical T1 Renal Masses: A Prospective StudyAmir Feinberg, Kathryn H Gessner, Allison M Deal, et al.
Urologic Oncology|July 1, 2015
Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settingsTracy L Rose, Allison M Deal, Ethan Basch, et al.
Plos One|December 27, 2014
Expression of Ror2 mediates invasive phenotypes in renal cell carcinomaNeal R Rasmussen, Zufan Debebe, Tricia M Wright, et al.
Urology|November 20, 2020
Implementation of Postoperative Standard Opioid Prescribing Schedules Reduces Opioid Prescriptions Without Change in Patient-reported Pain OutcomesKathryn H Gessner, Jaehyuk Jung, Hannah E Cook, et al.
JCI Insight|November 19, 2020
Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinomaChristopher G Wood, James E Ferguson, Joel S Parker, et al.
The Journal of Clinical Investigation|August 24, 2018
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinomaChristof C Smith, Kathryn E Beckermann, Dante S Bortone, et al.
Pageof 15

Showing results (121-130 of 144) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2010
Neoadjuvant clinical trial with sorafenib for patients with stage II or higher renal cell carcinomaC Lance Cowey, Chirag Amin, Raj S Pruthi, et al.
Urology Practice|March 31, 2026
Early Subspecialization Alignment: How Residents Tailor Experiences Before FellowshipSri Saran Manivasagam, Raidizon Mercedes, Gary E Lemack, et al.
Journal of Surgical Education|January 23, 2025
Impact of Subsequent Fellowship on Urology Chief Resident Case Log VolumesRaidizon Mercedes, Zachary Corey, Talmadge Gaither, et al.
Urology Practice|August 28, 2024
Practice Readiness? Trends in Chief Resident Case Logs vs Subsequent Case Log Data in Clinical PracticeZachary Corey, Erik Lehman, Gary E Lemack, et al.
The Journal of Urology|May 8, 2024
Decisional Conflict Among Patients Newly Diagnosed With Clinical T1 Renal Masses: A Prospective StudyAmir Feinberg, Kathryn H Gessner, Allison M Deal, et al.
Urologic Oncology|July 1, 2015
Neoadjuvant chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evaluation of transitions between academic and community settingsTracy L Rose, Allison M Deal, Ethan Basch, et al.
Plos One|December 27, 2014
Expression of Ror2 mediates invasive phenotypes in renal cell carcinomaNeal R Rasmussen, Zufan Debebe, Tricia M Wright, et al.
Urology|November 20, 2020
Implementation of Postoperative Standard Opioid Prescribing Schedules Reduces Opioid Prescriptions Without Change in Patient-reported Pain OutcomesKathryn H Gessner, Jaehyuk Jung, Hannah E Cook, et al.
JCI Insight|November 19, 2020
Neoadjuvant pazopanib and molecular analysis of tissue response in renal cell carcinomaChristopher G Wood, James E Ferguson, Joel S Parker, et al.
The Journal of Clinical Investigation|August 24, 2018
Endogenous retroviral signatures predict immunotherapy response in clear cell renal cell carcinomaChristof C Smith, Kathryn E Beckermann, Dante S Bortone, et al.
Pageof 15